FTV — Fortive Corporation

Post-earnings, FTV faded roughly 7% from its highs despite a Q2 beat and a dividend hike—a 'good news, muted reaction' tape. The sell-side is stuck at Hold, with a $64.67 consensus target, 11 buys versus 17 holds and 2 sells, and no Strong Buy ratings. Technicals are flat and range-bound, so the market is constructive but not enthusiastic.

Raw FMP quarterly revenue looks like a cliff—$1.52B in Q2 2025 to $1.03B in Q3 2025—but that is a portfolio reshaping/spin-off, not an operating collapse; stockholders' equity also dropped from $10.38B to $6.50B in the same step. On the continuing business, Q2 2026 revenue was $1.10B, up 7.9% year over year per the research brief, with adjusted EPS of $0.74 beating the $0.71 consensus. As-reported Q2 2026 gross margin was ~63.4% and operating margin was ~19.1%. This is a stable-to-modestly-improving trend, not the deteriorating picture the unadjusted YoY revenue decline implies.

Expensive on trailing GAAP: 34.8x P/E and 4.2x sales versus 5-year averages of 27.1x and 3.31x. But those trailing multiples are distorted by the spin-off. Forward is the cleaner lens: $59.92 divided by roughly $3.00 FY2026 adjusted EPS midpoint is about 20x. For a company growing high-single-digit revenue, with ~19% operating margins and roughly 50% recurring revenue, ~20x forward is fair-to-slightly-rich—not a bargain. The 0.39% dividend yield adds little valuation support.

At $59.92 the market is paying roughly 20x this year's guided EPS and is relying on management to deliver the $2.95–$3.05 range. The stock is not discounting a major growth reacceleration. If Q3 pushes guidance toward the top of the range, $3.05 at a 20x multiple would imply about $61; if growth disappoints, a reversion toward 18x would put the stock in the mid-$50s. The setup is roughly balanced with a modest downside skew, which argues against paying up here.

As of 2026-08-27, RSI stood at 46.5 (neutral), price was 0.97% below the 20-day SMA, 1.84% below the 50-day SMA, and 3.54% above the 200-day SMA—implying a 200-day level near $57.9. That is a range-bound consolidation after the post-earnings fade, not a new downtrend or breakout. Entry-timing implication: no urgency; better risk/reward near the 50/200-day zone around $57–58 unless price decisively clears the $61–62 area.

• Interest-rate expectations: as a 20x forward P/E industrial-tech name, FTV is sensitive to shifts in the Fed's rate path and long-term discount rates.
• Short-cycle industrial demand: slower global growth is a modest headwind to test-and-measurement, field services, and manufacturing-related spending.
• Recurring revenue tailwinds: high-margin software/services, now roughly half the portfolio, provide more stability than pure hardware cycles.
• Post-spin capital structure: the balance sheet reset with lower equity and higher long-term debt, so capital allocation and deleveraging matter more.
• Global manufacturing and FX: international exposure creates translation and demand volatility from macro cycles.

• Q3 2026 earnings, expected late October/early November 2026—whether FTV raises or simply reaffirms the upper half of its $2.95–$3.05 EPS guidance.
• Continued organic growth and ARR expansion in software/services, especially if Fluke and maintenance-software demand accelerate.
• Fed rate cuts that could re-rate long-duration, high-quality industrial technology names like FTV.
• Capital deployment: further share buybacks, debt paydown, or M&A funded by free cash flow after the spin-off.

• A global industrial recession or prolonged short-cycle spending pause would pressure revenue and margins.
• Spin-off execution risk: integration, stranded costs, or unexpected leverage/working-capital drag in the reshaped portfolio.
• Multiple de-rating from a rich historical valuation if organic growth fades or free cash flow conversion disappoints.
• Analyst skepticism: 17 Holds and 2 Sells versus only 11 Buys suggest limited near-term catalysts to force a re-rating.
• Competitive pressure in test equipment, field instrumentation, and industrial software could squeeze growth and pricing.

Fortive is a reasonably high-quality industrial-tech business with a 20x forward multiple and improving but not compelling organic growth. The deterministic score calls fundamentals weak, valuation is rich versus its own history, and the analyst base is stuck at Hold. At $59.92 I see modest downside to my $57.30 fair value and no essential catalyst to buy now; I would wait for a cheaper entry near $55–57 or evidence of acceleration toward the top of guidance. This is analysis, not personalized investment advice.

I applied a 19.0x multiple to the next-fiscal-year EPS estimate of $3.02 (consistent with the guided midpoint of $3.00), one turn below the current ~20x forward multiple to reflect the rich historical valuation, subpar ROIC, and macro uncertainty around short-cycle industrial demand. That yields a fair value of approximately $57.30.